collection
https://read.qxmd.com/read/33338197/reinfection-with-sars-cov-2-implications-for-vaccines
#21
REVIEW
Jeffrey I Cohen, Peter D Burbelo
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic and the duration of protective immunity to the virus is unknown. Cases of persons reinfected with the virus are being reported with increasing frequency. At present it is unclear how common reinfection with SARS-CoV-2 is and how long serum antibodies and virus-specific T cells persist after infection. For many other respiratory virus infections, including influenza and the seasonal coronaviruses that cause colds, serum antibodies persist for only months to a few years and reinfections are very common...
December 6, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33093467/neuromyelitis-optica
#22
REVIEW
Sven Jarius, Friedemann Paul, Brian G Weinshenker, Michael Levy, Ho Jin Kim, Brigitte Wildemann
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome characterized by attacks of acute optic neuritis and transverse myelitis. In most patients, NMO is caused by pathogenetic serum IgG autoantibodies to aquaporin 4 (AQP4), the most abundant water-channel protein in the central nervous system. In a subset of patients negative for AQP4-IgG, pathogenetic serum IgG antibodies to myelin oligodendrocyte glycoprotein, an antigen in the outer myelin sheath of central nervous system neurons, are present...
October 22, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/33315494/stroke-prevention-in-atrial-fibrillation-looking-forward
#23
REVIEW
Aristeidis H Katsanos, Hooman Kamel, Jeff S Healey, Robert G Hart
Ischemic strokes related to atrial fibrillation are highly prevalent, presenting with severe neurologic syndromes and associated with high risk of recurrence. Although advances have been made in both primary and secondary stroke prevention for patients with atrial fibrillation, the long-term risks for stroke recurrence and bleeding complications from antithrombotic treatment remain substantial. We summarize the major advances in stroke prevention for patients with atrial fibrillation during the past 30 years and focus on novel diagnostic and treatment approaches currently under investigation in ongoing clinical trials...
December 15, 2020: Circulation
https://read.qxmd.com/read/33310884/ammonia-what-adult-neurologists-need-to-know
#24
JOURNAL ARTICLE
Rick Meijer, Umesh Vivekananda, Simona Balestrini, Matthew Walker, Robin Lachmann, Johannes Haeberle, Elaine Murphy
Hyperammonaemia is often encountered in acute neurology and can be the cause of acute or chronic neurological symptoms. Patients with hyperammonaemia may present with seizures or encephalopathy, or may be entirely asymptomatic. The underlying causes are diverse but often straightforward to diagnose, although sometimes require specialist investigations. Haemodialysis or haemo(dia)filtration is the first-line treatment for acute severe hyperammonaemia (of any cause) in an adult. Here we discuss our approach to adult patients with hyperammonaemia identified by a neurologist...
December 11, 2020: Practical Neurology
https://read.qxmd.com/read/33315071/diagnosis-of-progressive-multiple-sclerosis-from-the-imaging-perspective-a-review
#25
REVIEW
Massimo Filippi, Paolo Preziosa, Frederik Barkhof, Declan T Chard, Nicola De Stefano, Robert J Fox, Claudio Gasperini, Ludwig Kappos, Xavier Montalban, Bastiaan Moraal, Daniel S Reich, Àlex Rovira, Ahmed T Toosy, Anthony Traboulsee, Brian G Weinshenker, Burcu Zeydan, Brenda L Banwell, Maria A Rocca
IMPORTANCE: Although magnetic resonance imaging (MRI) is useful for monitoring disease dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there has been less application of MRI to progressive MS, including diagnosing primary progressive (PP) MS and identifying patients with relapsing-remitting (RR) MS who are at risk of developing secondary progressive (SP) MS. This review addresses clinical application of MRI for both diagnosis and prognosis of progressive MS...
March 1, 2021: JAMA Neurology
https://read.qxmd.com/read/33288539/acute-intracerebral-haemorrhage-diagnosis-and-management
#26
JOURNAL ARTICLE
Iain J McGurgan, Wendy C Ziai, David J Werring, Rustam Al-Shahi Salman, Adrian R Parry-Jones
Intracerebral haemorrhage (ICH) accounts for half of the disability-adjusted life years lost due to stroke worldwide. Care pathways for acute stroke result in the rapid identification of ICH, but its acute management can prove challenging because no individual treatment has been shown definitively to improve its outcome. Nonetheless, acute stroke unit care improves outcome after ICH, patients benefit from interventions to prevent complications, acute blood pressure lowering appears safe and might have a modest benefit, and implementing a bundle of high-quality acute care is associated with a greater chance of survival...
December 7, 2020: Practical Neurology
https://read.qxmd.com/read/33248499/direct-oral-anticoagulants-evidence-and-unresolved-issues
#27
REVIEW
Noel Chan, Magdalena Sobieraj-Teague, John W Eikelboom
Currently licenced direct oral anticoagulants selectively target thrombin (eg, dabigatran) or coagulation factor Xa (eg, apixaban, betrixaban, edoxaban, and rivaroxaban). Designed to be given in fixed doses without routine monitoring, direct oral anticoagulants have a lower propensity for food and drug interactions than do vitamin K antagonists, and in randomised controlled trials involving around 250 000 patients, they were at least as effective for prevention and treatment of thrombosis and were associated with a lower risk of life-threatening bleeding...
November 28, 2020: Lancet
https://read.qxmd.com/read/33145709/pharmacological-management-of-painful-peripheral-neuropathies-a-systematic-review
#28
REVIEW
Andreas Liampas, Martina Rekatsina, Athina Vadalouca, Antonella Paladini, Giustino Varrassi, Panagiotis Zis
INTRODUCTION: Peripheral neuropathic pain (PNP) arises either acutely or in the chronic phase of a lesion or disease of the peripheral nervous system and is associated with a notable disease burden. The management of PNP is often challenging. The aim of this systematic review was to evaluate current evidence, derived from randomized controlled trials (RCTs) that have assessed pharmacological interventions for the treatment of PNP due to polyneuropathy (PN). METHODS: A systematic search of the PubMed database led to the identification of 538 papers, of which 457 were excluded due to not meeting the eligibility criteria, and two articles were identified through screening of the reference lists of the 81 eligible studies...
June 2021: Pain and Therapy
https://read.qxmd.com/read/33188477/myelin-oligodendrocyte-glycoprotein-antibody-associated-disorder-a-new-inflammatory-cns-demyelinating-disorder
#29
JOURNAL ARTICLE
Manjunath Netravathi, Vikram Venkappayya Holla, Atchayaram Nalini, Ravi Yadav, Seena Vengalil, Abel Thomas Oommen, Sultana Shaik Reshma, Nitish Kamble, Priya Treesa Thomas, Bhat Maya, Pramod Kumar Pal, Anita Mahadevan
BACKGROUND AND AIMS: Myelin oligodendrocyte glycoprotein (MOG) is an oligodendrocytopathy resulting in demyelination. We aimed to determine the frequency of MOG-associated disorders (MOGAD), its various clinical phenotypes, and imaging characteristics. METHODS: All patients with MOGAD were included. Description of the various clinical phenotypes, investigation profile, therapeutic response, differences between pediatric and adult-onset neurological disorders, determination of poor prognostic factors was done...
April 2021: Journal of Neurology
https://read.qxmd.com/read/33208545/pearls-oy-sters-anisocoria-greater-in-the-dark-it-s-not-just-all-about-horner-pupil
#30
JOURNAL ARTICLE
Emily Witsberger, Sasha A Mansukhani, John J Chen, M Tariq Bhatti
No abstract text is available yet for this article.
April 13, 2021: Neurology
https://read.qxmd.com/read/33208548/paraneoplastic-myeloneuropathies-clinical-oncologic-and-serologic-accompaniments
#31
JOURNAL ARTICLE
Shailee Shah, Rocio Vazquez Do Campo, Neeraj Kumar, Andrew McKeon, Eoin P Flanagan, Christopher Klein, Sean J Pittock, Divyanshu Dubey
OBJECTIVE: To test the hypothesis that myeloneuropathy is a presenting phenotype of paraneoplastic neurologic syndromes we retrospectively reviewed clinical, radiologic, and serologic features of 32 patients with concomitant paraneoplastic spinal cord and peripheral nervous system involvement. METHODS: Observational study investigating patients with myeloneuropathy and underlying cancer or onconeural antibody seropositivity. RESULTS: Among 32 patients with paraneoplastic myeloneuropathy, 20 (63%) were women with median age 61 years (range 27-84 years)...
January 26, 2021: Neurology
https://read.qxmd.com/read/33196579/the-2020-breakthroughs-in-early-secondary-prevention-dual-antiplatelet-therapy-versus-single-antiplatelet-therapy
#32
REVIEW
Odysseas Kargiotis, Georgios Tsivgoulis
PURPOSE OF REVIEW: Single antiplatelet therapy represents an established treatment in secondary prevention of ischemic strokes and transient ischemic attacks (TIAs). In contrast with coronary artery disease, the use of dual antiplatelet therapy (DAPT) for secondary prevention in patients with acute cerebral ischemia (ACI) remains under debate. In this narrative review, we present and analyse the most recent findings concerning the potential efficacy and safety of DAPT therapy after ischemic strokes or TIA...
February 1, 2021: Current Opinion in Neurology
https://read.qxmd.com/read/33186537/new-therapies-for-neuromyelitis-optica-spectrum-disorder
#33
REVIEW
Michael Levy, Kazuo Fujihara, Jacqueline Palace
BACKGROUND: Neuromyelitis optica spectrum disorder is an autoimmune disease of the CNS that primarily affects the optic nerves and spinal cord. Most patients have serum antibodies targeting the aquaporin-4 water channel expressed on the end-feet of astrocytes. Although the prevalence of neuromyelitis optica spectrum disorder is limited to around 1-2 people per 100 000, severe immune-mediated attacks can quickly lead to blindness and paralysis if undiagnosed and untreated. However, diagnosis is straightforward when the highly specific serum aquaporin-4 antibodies are detected with cell-based assays...
January 2021: Lancet Neurology
https://read.qxmd.com/read/33129443/long-term-ocrelizumab-in-progressive-multiple-sclerosis
#34
COMMENT
Deja R Rose, Jeffrey A Cohen
No abstract text is available yet for this article.
December 2020: Lancet Neurology
https://read.qxmd.com/read/33144515/international-consensus-guidance-for-management-of-myasthenia-gravis-2020-update
#35
REVIEW
Pushpa Narayanaswami, Donald B Sanders, Gil Wolfe, Michael Benatar, Gabriel Cea, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L Kuntz, Janice Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David Richman, Jan Verschuuren
OBJECTIVE: To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to 7 treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America...
January 19, 2021: Neurology
https://read.qxmd.com/read/33078475/association-between-migraine-and-cryptogenic-ischemic-stroke-in-young-adults
#36
JOURNAL ARTICLE
Nicolas Martinez-Majander, Ville Artto, Pauli Ylikotila, Bettina von Sarnowski, Ulrike Waje-Andreassen, Nilufer Yesilot, Marialuisa Zedde, Juha Huhtakangas, Heikki Numminen, Pekka Jäkälä, Ana C Fonseca, Petra Redfors, Marieke J H Wermer, Alessandro Pezzini, Jukka Putaala
OBJECTIVE: To assess the association between migraine and cryptogenic ischemic stroke (CIS) in young adults, with subgroup analyses stratified by sex and presence of patent foramen ovale (PFO). METHODS: We prospectively enrolled 347 consecutive patients aged 18 to 49 years with a recent CIS and 347 age- and sex-matched (±5 years) stroke-free controls. Any migraine and migraine with (MA) and migraine without aura (MO) were identified by a screener, which we validated against a headache neurologist...
February 2021: Annals of Neurology
https://read.qxmd.com/read/32761278/bilateral-lesions-of-the-basal-ganglia-and-thalami-central-grey-matter-pictorial-review
#37
REVIEW
Sofie Van Cauter, Mariasavina Severino, Rosamaria Ammendola, Brecht Van Berkel, Hrvoje Vavro, Luc van den Hauwe, Zoran Rumboldt
The basal ganglia and thalami are paired deep grey matter structures with extensive metabolic activity that renders them susceptible to injury by various diseases. Most pathological processes lead to bilateral lesions, which may be symmetric or asymmetric, frequently showing characteristic patterns on imaging studies. In this comprehensive pictorial review, the most common and/or typical genetic, acquired metabolic/toxic, infectious, inflammatory, vascular and neoplastic pathologies affecting the central grey matter are subdivided according to the preferential location of the lesions: in the basal ganglia, in the thalami or both...
December 2020: Neuroradiology
https://read.qxmd.com/read/33064188/exacerbation-of-myasthenia-gravis-following-corticosteroid-treatment-what-is-the-evidence-a-systematic-review
#38
REVIEW
Itay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, Israel Steiner
Corticosteroids (CS) are among the most widely- used immunosuppressive agents for immune-mediated conditions, including myasthenia gravis (MG). While their effectiveness in MG is documented and supported in the clinical practice over several decades, one of the main drawbacks of treatment results from the notion that MG patients may experience symptom worsening following CS treatment initiation. This may lead to the administration of lower than necessary doses of CS for the disorder, or even avoiding them altogether...
December 2021: Journal of Neurology
https://read.qxmd.com/read/33093137/imaging-review-of-paraneoplastic-neurologic-syndromes
#39
REVIEW
A A Madhavan, C M Carr, P P Morris, E P Flanagan, A L Kotsenas, C H Hunt, L J Eckel, E P Lindell, F E Diehn
Paraneoplastic syndromes are systemic reactions to neoplasms mediated by immunologic or hormonal mechanisms. The most well-recognized paraneoplastic neurologic syndrome, both clinically and on imaging, is limbic encephalitis. However, numerous additional clinically described syndromes affect the brain, spinal cord, and peripheral nerves. Many of these syndromes can have imaging findings that, though less well described, are important in making the correct diagnosis. Moreover, imaging in these syndromes frequently mimics more common pathology, which can be a diagnostic challenge for radiologists...
December 2020: AJNR. American Journal of Neuroradiology
https://read.qxmd.com/read/33048220/an-overview-of-viral-infections-of-the-nervous-system-in-the-immunosuppressed
#40
REVIEW
Peter G E Kennedy
Several viruses have the capacity to cause serious infections of the nervous system in patients who are immunosuppressed. Individuals may be immunosuppressed because of primary inherited immunodeficiency, secondary immunodeficiency due to particular diseases such as malignancy, administration of immunosuppressant drugs or organ or bone marrow transplantation. The viruses capable of such opportunistic infection of the nervous system include herpes simplex virus (HSV), Varicella-Zoster virus (VZV), Cytomegalovirus (CMV), Epstein -Barr virus (EBV), Human Herpes virus type 6 (HHV-6), JC virus (JCV), enterovirus, measles virus and Covid-19...
August 2021: Journal of Neurology
label_collection
label_collection
7410
2
3
2020-10-26 07:27:54
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.